Digital vs. Analog Chest Drainage Systems for Pediatric Air Leak
(THOPAZ Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial compares digital and analog chest drainage systems for children with lung air leaks from conditions like spontaneous pneumothorax (a collapsed lung) or post-lung surgery. Researchers aim to determine if the digital system, which uses sensors to measure air leaks and maintain steady pressure, can reduce chest tube duration, the number of chest x-rays, and hospital stay length. Children under 18 who require a chest tube for these conditions at The Children's Hospital may qualify for this trial. As an unphased trial, it offers a unique opportunity to contribute to innovative research that could enhance future treatments for children with lung conditions.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that these chest drainage systems are safe for pediatric patients?
Research has shown that digital chest drainage systems, such as the Thopaz+, are generally safe. Studies in adults suggest these systems help remove chest tubes more quickly and shorten hospital stays, indicating their safety. They use sensors to detect air leaks and adjust pressure, maintaining stability and safety.
Analog chest drainage systems lack precise measurement, which can lead to longer drainage times and variability in patient care. However, these systems have been used for a long time and are well-established in the medical field.
Both systems are generally well-tolerated, but the digital system may offer greater safety and comfort due to its precise measurements. So far, no major reports of serious side effects have emerged from either system.12345Why are researchers excited about this trial?
Researchers are excited about the trial comparing digital and analog chest drainage systems for pediatric air leaks because these systems could potentially improve patient outcomes. The digital system, Thopaz+, stands out because it uses sensors to precisely measure air leaks and maintain constant negative pressure, which could lead to more consistent and quicker recovery times. Unlike traditional analog systems that rely on manual settings and subjective assessments of air leaks, the digital approach offers objective, real-time data that can help doctors decide the optimal time to remove the chest tube, potentially reducing hospital stays and healthcare costs. This trial aims to determine if these benefits seen in adults also apply to children, offering hope for better, more efficient care in pediatric patients.
What evidence suggests that digital chest tube drainage systems are effective for pediatric air leaks?
This trial will compare digital chest tube drainage systems, such as Thopaz+, with traditional analog systems for pediatric air leaks. Research has shown that digital systems can more accurately measure air leaks and maintain steady chest pressure, potentially leading to shorter drainage times and hospital stays. For adults, this also results in fewer chest x-rays and lower costs. Although studies on children are limited, early results suggest they might experience similar benefits. Traditional systems, in contrast, often take longer because they rely on manual pressure settings and personal judgment to assess air leaks.12367
Who Is on the Research Team?
Catherine Hunter, MD
Principal Investigator
University of Oklahoma
Are You a Good Fit for This Trial?
This trial is for children and teens up to 17 years old who need a chest tube placed due to a collapsed lung or after lung surgery at The Children's Hospital. It excludes those with cancerous fluid in the lungs, recent chemo or radiation, major organ failure, brain function issues, pus in the lung cavity, adults over 18, or if the tube is placed by neonatologists or pediatricians.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to either the digital (Thopaz+) or analog (Pleur-evac) drainage system and monitored for duration of chest tube drainage, length of stay, and air leaks.
Follow-up
Participants are monitored for safety and effectiveness after chest tube removal, including tracking of complications and recovery progress.
Data Analysis
Interim analysis will be performed once 12 patients per arm are accrued, with continued monitoring until the study is adequately powered.
What Are the Treatments Tested in This Trial?
Interventions
- Analog Chest Tube Drainage System
- Digital Chest Tube Drainage System (Thopaz+)
Analog Chest Tube Drainage System is already approved in European Union, United States for the following indications:
- Pulmonary resection
- Pneumothorax
- Thoracic trauma
- Pleural disease
- Pulmonary resection
- Pneumothorax
- Thoracic trauma
- Pleural disease
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Oklahoma
Lead Sponsor